In this article, the use of TAP and CEA to detect patients with thyroid nodules of type IV or above may increase the detection rate of thyroid cancer, reduce the rate of misdiagnosis and misdiagnosis, and reduce the risk of cancer. Here, CEACAM5 is linked to thyroid gland carcinoma.